Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2025-12-27 @ 9:53 PM
Study NCT ID:
NCT02891161
Status:
TERMINATED
Last Update Posted:
2024-11-27
First Post:
2016-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Sponsor:
Monika Joshi, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-01
First Submit QC Date:
None
Study First Post Date:
2016-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-06-29
Results First Submit QC Date:
None
Results First Post Date:
2024-11-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-27
Last Update Post Date Type:
ACTUAL